비타민 원료 시장 보고서 : 유형, 형태, 공급원, 용도, 지역별(2024-2032년)

The global vitamin ingredients market size reached US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Vitamin ingredients, or vitamers, refer to various organic compounds that exhibit similar properties to naturally occurring vitamins. They are obtained from fruits, vegetables and animal-based sources and are developed to fulfill nutritional deficiencies in the body. Water-soluble and fat-soluble are the two most commonly available vitamin ingredients. The water-soluble vitamers are used for immediate absorption and providing instant nourishment to the body and fat-soluble vitamers are diffused in fats and stored in the liver for later absorption. These vitamin ingredients aid in minimizing the risks of developing cardiovascular diseases, diabetes, eye disorders, signs of aging and heat strokes. As a result, they are widely used in the manufacturing of food and beverages, animal feed and pharmaceuticals.

The increasing prevalence of chronic medical ailments related to vitamin deficiencies, along with the rising geriatric population across the globe, represents one of the key factors driving the growth of the market. Furthermore, the rising demand for functional and nutritionally-enriched food products is creating a positive outlook for the market. Vitamins are considered to be an essential component of the daily diet as they aid in overall growth, digestion and neurological functions. Vitamin ingredients are used in the medical nutrition industry for the treatment of malnutrition and deficiency-related disorders. In line with this, the manufacturing of animal feed fortified with vitamers for enhanced nourishment in meat and dairy products is also contributing to the market growth. Additionally, various product innovations, such as the development of natural and allergen-free Vitamin E, are acting as other growth-inducing factors. These vitamers are extensively used in organic and herbal haircare, skincare, cosmetics and other personal care products, which, in turn, is driving the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global vitamin ingredients market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, form, source and application.

Breakup by Type:

Vitamin A

Vitamin B

Vitamin C

Vitamin D

Vitamin E

Vitamin K

Breakup by Form:

Tablets and Capsules

Powder

Others

Breakup by Source:

Natural

Synthetic

Breakup by Application:

Pharmaceuticals

Foods and Beverages

Personal Care Products

Animal Feed

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Archer Daniels Midland Company, BASF SA, Bluestar Adisseo Company, Btsa Biotecnologias Aplicadas S.L., Farbest-Tallman Foods Corp., Glanbia Plc, Koninklijke DSM N.V., Lonza Group, Nestle S.A., Pfizer Inc., Rabar Pty Ltd. and The Wright Group.

Key Questions Answered in This Report:

• How has the global vitamin ingredients market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global vitamin ingredients market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the form?
• What is the breakup of the market based on the source?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global vitamin ingredients market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Vitamin Ingredients Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Vitamin A
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Vitamin B
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Vitamin C
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Vitamin D
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Vitamin E
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Vitamin K
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Form

• 7.1 Tablets and Capsules
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Powder
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Source

• 8.1 Natural
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Synthetic
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Pharmaceuticals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Foods and Beverages
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Personal Care Products
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Animal Feed
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Archer Daniels Midland Company
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 BASF SA
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Bluestar Adisseo Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
  • 15.3.5 Btsa Biotecnologias Aplicadas S.L.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Farbest-Tallman Foods Corp.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Glanbia Plc
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Koninklijke DSM N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Lonza Group
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Nestle S.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Pfizer Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
  • 15.3.12 Rabar Pty Ltd.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
  • 15.3.13 The Wright Group
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio